17th May 2021 by Dr Louise Hudman
NICE has released a new guideline on the use of Baricitinib in moderate to severe atopic dermatitis. Baricitinib is a Janus kinase (JAK) inhibitor.
As JAK is essential for certain cytokine signalling, by disrupting JAK, you disrupt cytokine signalling and thus disrupt the body’s immune response.
It will be used fourth line (after normal GP treatments, phototherapy and 1 other systemic immunosuppressant).
Podcast | Diagnosis and management of actinic keratosis by Dr Tony Downs
We are joined by Dr Tony Downs for a talk on the management of actinic keratosis.
Video: Dr Tony Downs, actinic keratosis
Watch Dr Tony Downs's presentation, read slides and record CPD.
New GP clinical education event launches on skin cancer
GPs can hear the latest updates about skin cancer presentations and management in general practice as part of a clinical education event by NASGP.
"Before I used LocumDeck, some practices used to ignore my terms and conditions and add bookings to their diaries that they hadn't confirmed with me. Now, my terms and conditions get sent out with every communication and I can confirm sessions by email really easily. I love having a paper trail that's easy to follow – no more endless hunts through random emails. "
Dr Paula N, GP